Nasal tip schwannoma mimicking rhinophyma

Geyton, Thomas; Henderson, Arthur; Morris, Joseph E.; McDonald, Steve

doi:10.1136/bcr-2017-223495

Cited by 2 publications

(2 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is an estimated 3%-10% incidence of basal cell carcinoma in patients with rhinophyma; 16 however, frequency of malignancy is not reported to be increased in patients with rhinophyma. Conditions reported to occur within rhinophyma include basal cell carcinoma, [16][17][18][19][20][21][22] cutaneous squamous cell carcinoma, 23,24 B-cell neoplasms, [25][26][27] schwannoma, 28 cutaneous angiosarcoma, 23,29,30 and sebaceous carcinoma. 31,32…”

Section: Differential Diagnosismentioning

confidence: 99%

<p>Rhinophyma: Prevalence, Severity, Impact and Management</p>

Chauhan

Loewenstein

Hassanein

2020

CCID

View full text Add to dashboard Cite

Rhinophyma is an advanced stage of rosacea affecting the nasal soft tissues and resulting in disruption of the nasal architecture, airway obstruction, and disfigurement of the nasal aesthetic units. Rhinophyma presents with hypertrophy of the nasal soft tissues, erythema, telangiectasias, nodules, and lobules with a bulbous appearance. Significant psychosocial morbidity is associated with the disease. Understanding of this disease has improved and multiple treatment options exist. The article is a review of the literature to evaluate the pathophysiology, clinical presentation, and epidemiology of keywords "rhinophyma" and "rosacea" using an OVID Medline and PubMed search along with a systematic review of outcomes pertaining to treatment of rhinophyma with laser therapy, scalpel excision, and the subunit method using an OVID Medline search. The subunit method has the highest complication and revision rates followed by carbon dioxide laser therapy. Outcomes between carbon dioxide laser and scalpel therapy and electrocautery are equivalent. Scalpel excision is a more cost-effective treatment modality with less post-operative complications; however, it risks poor hemostasis intraoperatively. Patient satisfaction is common post-therapy regardless of the treatment method. Over 89% of patients would recommend undergoing treatment for rhinophyma irrespective of treatment type. Treatment options vary, and choice of treatment can be dependent on practitioner and patients' treatment goals.

show abstract

Section: Differential Diagnosismentioning

confidence: 99%

<p>Rhinophyma: Prevalence, Severity, Impact and Management</p>

Chauhan

Loewenstein

Hassanein

2020

CCID

View full text Add to dashboard Cite

show abstract

“…Typically, neoplasms such as basal cell carcinoma (present in approximately 3% of cases 10 ), squamous cell carcinoma, 10 schwannoma, 11 cutaneous angiosarcoma, 12 and B-cell neoplasm 13 coexist with rhinophyma. However, it has not been clearly established whether rhinophyma itself acts as a precancerous condition, especially since these neoplasms are typically identified in a single location and in a clinically significant stage.…”

Section: Introductionmentioning

confidence: 99%